Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Journal of Medicinal Chemistry
|
June 30, 2022
Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance
Arianna Colini Baldeschi, Marco Zattoni, Silvia Vanni, et al.
Journal of Medicinal Chemistry
|
October 22, 2015
Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders
Guido Furlotti, Maria Alessandra Alisi, Nicola Cazzolla, et al.
Journal of Medicinal Chemistry
|
April 7, 2023
Design, Synthesis, <i>In Vitro</i> and <i>In Vivo</i> Characterization of CDC42 GTPase Interaction Inhibitors for the Treatment of Cancer
Nicoletta Brindani, Linh M Vuong, Isabella Maria Acquistapace, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 15, 2025
Exposure of dams to Elexacaftor/ Tezacaftor/Ivacaftor during pregnancy and breastfeeding induces reversible alterations in newborn wild type CD-1 mice
Angelica Squarzoni, Gaia Boschetti, Sine Mandrup Bertozzi, et al.
Journal of Medicinal Chemistry
|
October 20, 2020
Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β
Jose Antonio Ortega, Jose M Arencibia, Elirosa Minniti, et al.
Journal of Medicinal Chemistry
|
June 12, 2024
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy
Nicoletta Brindani, Linh M Vuong, Maria Antonietta La Serra, et al.
Angewandte Chemie (International Ed. in English)
|
December 16, 2014
Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3β inhibitors
Federica Prati, Angela De Simone, Paola Bisignano, et al.
Journal of Medicinal Chemistry
|
April 29, 2026
A Polypharmacology-Driven Approach to Alzheimer's Disease and Tauopathies: Rational Design, Synthesis and Characterization of Amino-Pyrazole-Based Multikinase (GSK-3β/FYN-α/DYRK1A) Inhibitors
Stefania Demuro, Debora Russo, Ilaria Penna, et al.
ACS Chemical Neuroscience
|
July 15, 2015
3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease
Federica Prati, Angela De Simone, Andrea Armirotti, et al.
Journal of Medicinal Chemistry
|
December 8, 2020
Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors
Samantha Caputo, Simona Di Martino, Vincenzo Cilibrasi, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Journal of Medicinal Chemistry
|
June 30, 2022
Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance
Arianna Colini Baldeschi, Marco Zattoni, Silvia Vanni, et al.
Journal of Medicinal Chemistry
|
October 22, 2015
Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders
Guido Furlotti, Maria Alessandra Alisi, Nicola Cazzolla, et al.
Journal of Medicinal Chemistry
|
April 7, 2023
Design, Synthesis, <i>In Vitro</i> and <i>In Vivo</i> Characterization of CDC42 GTPase Interaction Inhibitors for the Treatment of Cancer
Nicoletta Brindani, Linh M Vuong, Isabella Maria Acquistapace, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 15, 2025
Exposure of dams to Elexacaftor/ Tezacaftor/Ivacaftor during pregnancy and breastfeeding induces reversible alterations in newborn wild type CD-1 mice
Angelica Squarzoni, Gaia Boschetti, Sine Mandrup Bertozzi, et al.
Journal of Medicinal Chemistry
|
October 20, 2020
Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β
Jose Antonio Ortega, Jose M Arencibia, Elirosa Minniti, et al.
Journal of Medicinal Chemistry
|
June 12, 2024
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy
Nicoletta Brindani, Linh M Vuong, Maria Antonietta La Serra, et al.
Angewandte Chemie (International Ed. in English)
|
December 16, 2014
Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3β inhibitors
Federica Prati, Angela De Simone, Paola Bisignano, et al.
Journal of Medicinal Chemistry
|
April 29, 2026
A Polypharmacology-Driven Approach to Alzheimer's Disease and Tauopathies: Rational Design, Synthesis and Characterization of Amino-Pyrazole-Based Multikinase (GSK-3β/FYN-α/DYRK1A) Inhibitors
Stefania Demuro, Debora Russo, Ilaria Penna, et al.
ACS Chemical Neuroscience
|
July 15, 2015
3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease
Federica Prati, Angela De Simone, Andrea Armirotti, et al.
Journal of Medicinal Chemistry
|
December 8, 2020
Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors
Samantha Caputo, Simona Di Martino, Vincenzo Cilibrasi, et al.
Page
of 7